SUMMARY Plasma concentrations of cardiodilatin, the peptide sequence at the amino terminal of the pro-atrial natriuretic peptide, in 17 normal subjects ranged from 59 to 202 (mean 118 (SEM) (9)) pmol/l. Recumbency increased the mean (SEM) concentration to 160 (13) 
SUMMARY Plasma concentrations of cardiodilatin, the peptide sequence at the amino terminal of the pro-atrial natriuretic peptide, in 17 normal subjects ranged from 59 to 202 (mean 118 (SEM) (9) ) pmol/l. Recumbency increased the mean (SEM) concentration to 160 (13) pmol/l. The plasma concentration of cardiodilatin in 24 patients with congestive cardiac failure was much higher (964 (175) pmol/l) than in the normal subjects. It was highest in those with heart failure in New York Heart Association functional classes III and IV and the concentration correlated both with atrial natriuretic peptide concentrations and left ventricular ejection fraction. Concentrations rose during induced tachycardia in three patients tested. Chromatography showed a single clean peak of plasma cardiodilatin immunoreactivity. It seems that cardiodilatin is a second circulating cardiac peptide that is jointly released with atrial natriuretic peptide by common stimuli.
Other workers have reported that, like atrial natriuretic peptide, three partial cardiodilatin sequences can stimulate renal particulate guanylate cyclase and increase cyclic guanosine monophosphate. The simultaneous release of cardiodilatin in higher circulating concentrations than atrial natriuretic peptide may be relevant to the finding that appropriate concentrations of exogenous atrial natiuretic peptide alone do not produce the full renal effects associated with endogenous peptide release.
Atrial natriuretic peptide is present in the atrium ' (9) ) with stable chronic congestive cardiac failure. The aetiology of the cardiac failure was ischaemic (n = 15) or dilated (n = 9) cardiomyopathy. Three patients were in New York Heart Association functional class I, eight in class II, 10 in class III, and three in class IV. Left ventricular ejection fraction was measured in 21 patients by radionuclide ventriculography28 within 48 hours of blood sampling. The patients were on maintenance drug treatment as follows: diuretics (24), angiotensin converting enzyme inhibitors (10), nitrates (4), digoxin (4), aspirin/anticoagulants (10) , fl-blockers (1) , and amiodarone (2). Samples of peripheral venous blood were taken between 0800 and 0900 after an overnight fast with the patient in the supine position and processed as described above. Samples were also taken from three patients before and during tachycardia, induced by an extra systole and maintained for 10 Peptide concentrations are on a log scale. Meleagros, Gibbs, Ghatei, Bloom plasma cardiodilatin. This stimulus is also known to increase atrial natriuretic peptide'4 3738 and was attributed to increased intrathoracic blood volume causing atrial distension.
Abnormal atrial distension in congestive cardiac failure was also associated with raised concentrations of atrial natriuretic peptide."'0 The present study shows that plasma cardiodilatin was also greatly increased and correlated with atrial natriuretic peptide in patients with congestive cardiac failure. The relations between atrial natriuretic peptide and left ventricular ejection fraction'39 and New York Heart Association functional class9 " were confirmed in our study. We also found that cardiodilatin was significantly related to both these variables. 
